Search Results - subject:"Bupropion"

The mean willingness-to-pay for smoking cessation treatment in Malaysia

Jin, Chuah Seong; Norashidah Mohamed Nor; Zaiton Samdin; … - In: International journal of economic policy in emerging … 17 (2023) 1, pp. 88-99

Persistent link: https://www.econbiz.de/10014308285

Nationwide Smoking Cessation Treatment Support Program – Turkey project

Çelik, İsmail; Yüce, Deniz; Hayran, Mutlu; Erman, Mustafa - In: Health Policy 119 (2015) 1, pp. 50-56

In 2011, Turkish Ministry of Health (MoH) initiated a nation-wide “Smoking Cessation Treatment Support Program” (SCTSP), to provide smoking cessation drugs free of charge.

Persistent link: https://www.econbiz.de/10011190146

A Discrete-Event Simulation of Smoking-Cessation Strategies Based on Varenicline Pivotal Trial Data

Xenakis, James G.; Kinter, Elizabeth T.; Ishak, K. Jack.; … - In: PharmacoEconomics 29 (2011) 6, pp. 497-510

pooled pivotal clinical trials of varenicline versus bupropion or placebo for smoking cessation and to provide a foundation … daily (bid) or bupropion SR 150 mg bid versus placebo (i.e. brief counselling only). The treatment periods in the clinical … cost-effectiveness outcomes. Results: For the varenicline, bupropion and placebo cohorts, respectively, the model predicted …

Persistent link: https://www.econbiz.de/10010614314

Successful Smoking Cessation

Huber, Gary L.; Mahajan, Vijay K. - In: Disease Management and Health Outcomes 16 (2008) 5, pp. 335-343

smoking cessation. Bupropion was developed as an antidepressant, but has been shown to reduce the desire to smoke. Bupropion …

Persistent link: https://www.econbiz.de/10005448749

Cost-Utility Analysis of Varenicline versus Existing Smoking Cessation Strategies using the BENESCO Simulation Model: Application to a Population of US Adult Smokers

Howard, Paul; Knight, Christopher; Boler, Annabel; … - In: PharmacoEconomics 26 (2008) 6, pp. 497-511

make a one-time attempt to quit smoking. The smoking cessation strategies compared were varenicline, bupropion, nicotine …

Persistent link: https://www.econbiz.de/10005449002

Impact of Insurance Coverage on the Use and Effects of Smoking Cessation Medications

Solberg, Leif I. - In: Disease Management and Health Outcomes 13 (2005) 3, pp. 151-158

Tobacco use is not only the chief preventable cause of death, but it is also a very important contributor to the cause or complications of most chronic diseases. Therefore, facilitating smoking cessation should be very important to more effective disease management. Well-accepted, evidence-based...

Persistent link: https://www.econbiz.de/10005404613